# Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

> **NCT00332839** · PHASE4 · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 93 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Cyclosporin A (CsA)
- **DRUG:** Tacrolimus
- **DRUG:** Enteric Coated - Mycophenolate Sodium (EC-MPS)
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT00332839
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** The trial was terminated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.
- **Last updated:** 2014-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332839, "Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00332839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*